- Home
- IHRT vs TSHA Comparison
IHRT vs TSHA Comparison
Compare IHRT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- TSHA
- Stock Information
- Founded
- IHRT 1974
- TSHA 2019
- Country
- IHRT United States
- TSHA United States
- Employees
- IHRT N/A
- TSHA N/A
- Industry
- IHRT Broadcasting
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- TSHA Health Care
- Exchange
- IHRT Nasdaq
- TSHA Nasdaq
- Market Cap
- IHRT 310.3M
- TSHA 334.1M
- IPO Year
- IHRT 2019
- TSHA 2020
- Fundamental
- Price
- IHRT $1.65
- TSHA $1.70
- Analyst Decision
- IHRT Buy
- TSHA Strong Buy
- Analyst Count
- IHRT 3
- TSHA 8
- Target Price
- IHRT $2.83
- TSHA $6.63
- AVG Volume (30 Days)
- IHRT 1.1M
- TSHA 1.6M
- Earning Date
- IHRT 05-08-2025
- TSHA 02-26-2025
- Dividend Yield
- IHRT N/A
- TSHA N/A
- EPS Growth
- IHRT N/A
- TSHA N/A
- EPS
- IHRT N/A
- TSHA N/A
- Revenue
- IHRT $3,854,532,000.00
- TSHA $8,333,000.00
- Revenue This Year
- IHRT $1.80
- TSHA N/A
- Revenue Next Year
- IHRT $5.22
- TSHA N/A
- P/E Ratio
- IHRT N/A
- TSHA N/A
- Revenue Growth
- IHRT 2.76
- TSHA N/A
- 52 Week Low
- IHRT $0.81
- TSHA $1.19
- 52 Week High
- IHRT $2.84
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- IHRT 39.82
- TSHA 54.32
- Support Level
- IHRT $1.48
- TSHA $1.66
- Resistance Level
- IHRT $1.95
- TSHA $1.79
- Average True Range (ATR)
- IHRT 0.20
- TSHA 0.11
- MACD
- IHRT -0.02
- TSHA 0.01
- Stochastic Oscillator
- IHRT 22.35
- TSHA 47.62
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.